Best GLP-1 Providers in South Carolina (2026)

See by medication

Looking for a specific GLP-1? Browse South Carolina providers by drug.

About GLP-1s in South Carolina

South Carolina permits telehealth GLP-1 prescriptions. South Carolina Medicaid (Healthy Connections) covers GLP-1s only for type 2 diabetes.

• •South Carolina's adult obesity rate is 35.4%
• •Healthy Connections Medicaid restricts GLP-1 coverage to diabetes
• •Charleston is a growing Southeast telehealth market

Top Cities for GLP-1 Treatment in South Carolina

Telehealth providers ship to all South Carolina addresses, but demand is highest in these metro areas:

Prefer an in-person clinic? Browse the South Carolina GLP-1 clinic directory →

GLP-1 Care Access in South Carolina: The Numbers

South Carolina has 511 NPI-registered in-person weight-management clinics across 75 cities — 11 with an obesity-medicine taxonomy, 184 endocrinology, and 320 bariatric — alongside 91 telehealth programs that ship to South Carolina addresses. The cheapest verified ongoing compounded semaglutide price available to South Carolina residents is $79/mo (tirzepatide: $97/mo). Full methodology and the 50-state table: GLP-1 care access by state.

Insurance & Medicaid in South Carolina

In Q1 2026, South Carolina Medicaid reimbursed approximately $15,775,343 across 16,018 GLP-1 prescriptions (all covered indications, gross before rebates — federal SDUD data; full state series here).

Most insurance plans in South Carolina cover GLP-1s for type 2 diabetes (Ozempic, Mounjaro), but coverage for obesity-only indications (Wegovy, Zepbound) is much more limited and often requires prior authorization. If your insurance won't cover brand-name GLP-1s, compounded semaglutide through telehealth is typically the most affordable option at around $195/mo.

For the exact criteria, drug list, and appeal process, read our South Carolina Medicaid GLP-1 coverage & prior-authorization guide. For coverage backdoors, Zepbound is FDA-approved for obstructive sleep apnea, and Wegovy for kidney and cardiovascular indications, which some plans cover even when they exclude weight-loss-only use.

Obesity in South Carolina

According to CDC data, 35.4% of South Carolina adults have obesity (BMI of 30 or higher). This places South Carolina at #11 out of 50 states. Access to GLP-1 medications like semaglutide and tirzepatide has expanded significantly through telehealth, helping South Carolina residents get clinically supervised weight loss treatment from home.

To choose a medication, compare the clinical-trial results behind each drug, see our best semaglutide and tirzepatide provider rankings, or track the next-generation GLP-1 pipeline.

Frequently Asked Questions